Immunotherapy

Thursday, September 8, 2016 - 3:19pm

The report released yesterday by the Cancer Moonshot Blue Ribbon Panel, a group convened by Vice President Biden last winter, highlighted some big ideas and high-impact opportunities in oncology.

Friday, July 22, 2016 - 1:15pm

During the Buffalo Cancer Moonshot Summit, Roswell Park joined a national conversation on how to end cancer as we know it. This initiative, backed by Vice President Joe Biden, intends to double the speed of cancer research and remove barriers to clinical trials by improving access to information.

Thursday, June 30, 2016 - 4:25pm

If you are considering starting a clinical trial, either because your doctor recommended it or because you or an advocate found a trial that seems appropriate, I have this easy advice: “GO FOR IT!” What have you got to lose? Trials are safe, well researched and documented. You, as a patient, are monitored and cared for like you never thought possible. You have so much to gain!

Tuesday, June 28, 2016 - 3:52pm

“Happy birthday to me.” KayEllen Gebhart says this in a flat voice, recalling her birthday in 2008 — the day she learned she had stage III ovarian cancer. The bad news came after a CT scan to find out what was causing the “tummy issues” her family doctor thought might be caused by her gallbladder.

Monday, June 27, 2016 - 1:56pm

Cancer immunotherapy, the practice of utilizing one’s own immune system to battle cancer cells, is a revolutionary treatment method and researchers at Roswell Park are helping blaze a trail.

Wednesday, April 27, 2016 - 11:22am

A native of Italy, Sebastiano Battaglia, PhD, also lived and studied in the United Kingdom, Germany and Luxembourg. After obtaining a fellowship at Roswell Park Cancer Institute, Dr. Battaglia intended for Buffalo to be yet another stop on his educational journey. Six years later, he is still here and is happy to call WNY home.

Monday, March 28, 2016 - 4:42pm

Roswell Park Cancer Institute made national headlines last April in securing an agreement to bring Cuba’s encouraging lung cancer vaccine, CimaVax, to the United States for clinical testing. Nearly one year later, Cuba is back in the news and CimaVax is receiving renewed attention. One of the most frequently asked questions about this vaccine is, “When will it be available for lung cancer patients in the U.S.?”

Thursday, October 15, 2015 - 9:43am

In 2015 alone, more than 21,000 women will receive a diagnosis of ovarian cancer and approximately 14,000 women will die of the disease. Often diagnosed at advanced stages, ovarian cancer is aggressive and particularly tough to treat.

Tuesday, September 1, 2015 - 2:20pm

Amid a historic normalizing of relations between the United States and Cuba, a potentially game-changing step was recently taken in the field of lung cancer research.

Tuesday, June 16, 2015 - 3:52pm

Last month, Roswell Park made headlines around the world with the announcement that we expect to be the first U.S. institution to offer a lung cancer treatment vaccine developed by the Center for Molecular Immunology in Cuba.